![]() | ![]() |
Formats:
|
||||||||||||||||||
Copyright © 1999, American Society for Microbiology Role in Cell Permeability of an Essential Two-Component System in Staphylococcus aureus Microcide Pharmaceuticals, Inc., Mountain View, California 94043 *Corresponding author. Mailing address: Microcide Pharmaceuticals, Inc., 850 Maude Ave., Mountain View, CA 94043. Phone: (650) 428-1550. Fax: (650) 428-3550. E-mail: martin/at/microcide.com. †Present address: PharmaNet, Inc., Blue Bell, PA 19422. ‡Present address: Iconix Pharmaceuticals, Inc., Mountain View, CA 94043. Received February 2, 1999; Accepted April 5, 1999. This article has been cited by other articles in PMC.Abstract A temperature-sensitive lethal mutant of Staphylococcus aureus was found to harbor a mutation in the uncharacterized two-component histidine kinase (HK)-response regulator (RR) pair encoded by yycFG; orthologues of yycFG could be identified in the genomes of Bacillus subtilis and other gram-positive bacteria. Sequence analysis of the mutant revealed a point mutation resulting in a nonconservative change (Glu to Lys) in the regulator domain of the RR at position 63. To confirm that this signal transduction system was essential, a disrupted copy of either the RR (yycF) or the HK (yycG) was constructed with a set of suicide vectors and used to generate tandem duplications in the chromosome. Resolution of the duplications, leaving an insertion in either the yycF or the yycG coding region, was achieved only in the presence of an additional wild-type copy of the two open reading frames. Phenotypic characterization of the conditional lethal mutant showed that at permissive growth conditions, the mutant was hypersusceptible to macrolide and lincosamide antibiotics, even in the presence of the ermB resistance determinant. Other mutant phenotypes, including hypersensitivity to unsaturated long-chain fatty acids and suppression of the conditional lethal phenotype by high sucrose and NaCl concentrations, suggest that the role of the two-component system includes the proper regulation of bacterial cell wall or membrane composition. The effects of this point mutation are strongly bactericidal at the nonpermissive temperature, indicating that this pathway provides an excellent target for the identification of novel antibiotics. The mounting problem of antibiotic resistance among pathogenic bacteria, including Staphylococcus aureus, has prompted renewed efforts toward the discovery of novel antimicrobial agents. Useful targets for novel antimicrobial agents will be found among genes that are essential for bacterial survival. In an effort to identify genes essential for the growth of S. aureus, a collection of temperature-sensitive (ts) mutants has been generated. One of the mutant strains, NT372, was found to be complemented by genes encoding a novel two-component signal transduction system. Two-component signal transduction systems are widely distributed among prokaryotes (6, 38) and mediate diverse adaptive responses (52), including sporulation (18), elaboration of virulence factors (34), and chemotaxis (31). Examples of structural homologues from eukaryotes have also been reported (25). A prokaryotic two-component system usually consists of a histidine kinase (HK) and a response regulator (RR). Commonly, an environmental signal is sensed by the HK, resulting in a change in the phosphorylation state of a conserved histidine residue in the cytoplasmic kinase domain of the protein. This phosphohistidyl residue serves as a source for phosphotransfer to a conserved aspartate residue of the cognate RR, resulting in modulation of the activity of the RR. The activated RR can initiate subsequent actions, such as transcriptional regulation or phosphorylation of other proteins, ultimately resulting in transduction of the primary signal. Several essential two-component systems have now been described for bacteria. An essential multicomponent pathway (60) in the dimorphic bacterium Caulobacter crescentus requires the RR gene ctrA (44) to restrict DNA replication to the stalked cell type, as well as to control the transcription of a number of genes (43). The resDE system is required for the proper expression of genes involved in respiration in Bacillus subtilis (55), although strains bearing insertional inactivations of either the HK or the RR are viable in the presence of glucose or fructose. A recent report has offered a preliminary characterization of the yycFG genes of B. subtilis (13); these genes are essential for the in vitro growth of B. subtilis and are orthologues of the genes described in this report. The two-component system identified in this work is essential for the in vitro viability of S. aureus. Several characteristics of the genes and mutant phenotypes suggest that they will be uniquely suitable for serving as targets for novel antibacterial agents. MATERIALS AND METHODS Media and chemicals. Antibiotics and medium supplements were obtained from Sigma (St. Louis, Mo.). Commercially available media for routine strain cultivation, including Trypticase soy broth (TSB), Mueller-Hinton broth, and Luria-Bertani broth, were obtained from Difco Laboratories (Detroit, Mich.). Chemically defined medium and dropout media were prepared as described by Pattee and Neveln (41). Oxyrase reagents and plates were purchased from Oxyrase, Inc. (Mansfield, Ohio) and used to generate anoxic growth conditions in combination with a GasPak chamber from BBL (Cockeysville, Md.). Selection for the drug resistance markers ermC and tetK was performed on Trypticase soy agar (TSA) plates (TSA with erythromycin [TSA-Em] or TSA with tetracycline [TSA-Tc], respectively) with 1 μg of antibiotic per ml for initial selection and scoring on 10 μg/ml. To select for the presence of the rescue plasmid, chloramphenicol (10 μg/ml) was added when required. Unless otherwise noted, strains carrying the yycF1 mutation were grown at 30°C as a permissive temperature; growth curves were acquired in a microtiter format with a SpectraMAXplus plate reader from Molecular Devices (Sunnyvale, Calif.). MICs were determined by twofold broth dilution on microtiter plates; end points were determined after overnight growth (35°C, 20 h). Bacterial strains and plasmids. The strains and vectors used in this work are listed in Table 1; all S. aureus strains used in this study were derivatives of 8325-4 (SAM23). The standard molecular biological procedures used are described by Sambrook et al. (45). All enzymes were purchased from New England Biolabs (Beverly, Mass.); deoxynucleotides were obtained from Pharmacia (Piscataway, N.J.). Recombinant constructs were introduced into bacteria either by electroporation with a Gene Pulser (BioRad, Inc.) or by transduction (47).
Mutant isolation and complementation. Heat-sensitive mutant NT372 was obtained by UV mutagenesis of S. aureus SAM23; mutagenized cultures were diluted, plated onto TSA, and incubated overnight (30°C, 18 h). The growing colonies were replica printed in duplicate and incubated under either permissive (30°C) or nonpermissive (43°C) growth conditions. Colonies growing at 30°C but not at 43°C were isolated, and their temperature-sensitive (TS) phenotypes were reconfirmed in a second round of plating. Genomic DNA for library construction and for PCR was prepared from S. aureus by the method of Dyer and Iandolo (12). Genomic DNA from SAM23 was partially digested (Sau3AI), and fragments (2 to 8 kb) were isolated by sucrose gradient centrifugation; the fragments were ligated into the pMP16 shuttle vector (BamHI), and the mixture was electroporated into Escherichia coli DH5α. The shuttle library plasmids were introduced into S. aureus SAM13 by electroporation; the pooled erythromycin-resistant (Emr) transformants were then infected with bacteriophage 11 at a multiplicity of infection of 0.01. The resulting lysates were used to transduce the ts mutant NT372 to temperature resistance for the selection of complementing clones. Transducing lysates of each of the colonies surviving incubation at 43°C were used to retransduce the original NT372 mutant to confirm the complementation.DNA sequence and analysis. Complementing plasmids and PCR amplicons were sequenced with a PRISM dye terminator kit from Applied Biosystems, Inc. (Foster City, Calif.) and an ABI 373A automated DNA sequencer. Oligonucleotides for DNA sequencing were produced on an ABI 392 synthesizer. All sequencing reactions were performed in multiple passes from both directions. Multiple genomic PCR amplicons from the NT372 mutant and the SAM23 parent were sequenced in parallel and compared to differentiate genomic mutations from possible PCR-induced artifacts. Version 8.0.1 of the Wisconsin Genetics Computer Group programs (11) was used for sequence analysis. Potential open reading frames (ORFs) were identified with Genemark (5) by use of an S. aureus matrix; similarity searches were performed with the BLASTX (1) program against the GenBank database (release 110). Strain construction. To generate a transposon insertion near the ts mutation in NT372, a Tn917lac transposon insertion library from SAM23 was generated with pLTV1 (42). A transducing lysate prepared from this insertion library was used to transduce the NT372 mutant to a temperature-resistant phenotype (26). In a modified protocol (see Results), the transduction mixture was plated on TSA-Em plates supplemented with sodium citrate (500 μg/ml) and Oxyrase (1:10 [vol/vol]). The plates were incubated under anoxic conditions until colonies began to appear (30°C, 48 h); colonies were reselected on TSA-Em plates at 43°C. A transducing lysate from one of the temperature-resistant derivatives, SAM970, was used to establish a genetic linkage between the transposon and the ts lesion (46). Genomic DNA flanking the transposon insertion was cloned in E. coli as described previously (62). Chromosomal digests (SmaI), used to map Tn917lac insertions and plasmid integrants (see below), were analyzed on a contour-clamped homogeneous electric field (CHEF) gel system (Bio-Rad) according to the manufacturer’s directions. The Tn917lac insertion identified in SAM970 was used to create the isogenic strains SAM1010 (yycF1) and SAM1011 (yycF+) by backcrossing into SAM23 (wild type). Disruption and rescue constructs. To generate integration constructs, the 3.7-kb yycFG genomic insert from the complementing plasmid (pMP373) was subcloned (EcoRI/HindIII) into pGEM3Zf(+), maintaining a rare SmaI site that could be used to map the integrants by CHEF gel analysis. A 2.1-kb fragment (HindIII) containing the tetK gene from plasmid pT181 was then introduced into the polylinker (pMP1008). A 1.2-kb fragment (MspI/ClaI) containing the ermC gene from plasmid pMIN164 was blunt ended (T4 DNA polymerase) and then introduced into one of two sites (Fig. (Fig.1):1
Each plasmid was introduced into S. aureus SAM13 by electroporation and selected on TSA-Tc plates. Chromosomal integrants were isolated and scored for tetracycline resistance; isolates bearing the ermC marker were also scored for erythromycin resistance. Site-specific integration of each construct was confirmed by CHEF gel analysis of a SmaI genomic digest; single-copy integration was confirmed by genomic PCR. Resolution of the tandem duplication, leaving a single disrupted copy of either ORF, was attempted by overnight growth in the absence of antibiotic selection. Single colonies were inoculated into TSB and grown to the postexponential phase (35°C, 24 h); the cultures were then diluted, plated on TSA, and allowed to grow overnight (35°C, 24 h). The resulting colonies were replica printed onto a selective medium (TSA-Tc); any colonies that were identified as tetracycline sensitive (Tcs) were scored for retention of the ermC insertion. The rescue plasmid (pMP782) was constructed by linearizing pC194 (HindIII) and ligating it into plasmid pMP621 (HindIII). The rescue plasmid was introduced by electroporation into strains bearing a tandem duplication of the yycFG locus (containing either a yycF::ermC or a yycG::ermC insertion in one copy) and selected on TSA containing chloramphenicol. Strains obtained in this manner were grown overnight (35°C, 18 h) in TSB supplemented with erythromycin (1 μg/ml) and then scored on TSA-Em plates. Colonies were replica plated onto TSA-Tc plates and examined for Tcs. The loss of the integration construct from the chromosome, indicated by the loss of the tetK marker and the loss of the additional SmaI site from the integration construct, was confirmed by CHEF gel analysis and genomic PCR. Transducing lysates were made from strains bearing either chromosomal disruption (yycF::ermC or yycG::ermC) and used to attempt to transduce SAM13, either with or without the rescue plasmid, to erythromycin resistance. RESULTS Mutant isolation and complementation. The S. aureus ts mutant NT372 was initially identified by its inability to form colonies on TSA plates at 43°C; subsequent experiments showed that it could not grow on any standard rich medium (solid or liquid) or in liquid or on solid defined medium (chemically defined medium) at temperatures above 40°C. A Tn917lac insertion linked to the TS phenotype in NT372 was identified (see Materials and Methods) and used to move the ts mutation into unmutagenized strain backgrounds. The isogenic strains SAM1010 (yycF1) and SAM1011 (yycF+) have the TS and temperature-insensitive growth phenotypes, respectively. SAM1010 failed to form colonies on rich and defined media at 43°C, demonstrating that a single locus was solely responsible for the inability of NT372 to grow at a high temperature. CHEF gel analysis of a SmaI chromosomal digest followed by Southern hybridization with a probe specific for Tn917lac localized the transposon insertion to the SmaI-G fragment (data not shown). Sequence analysis of a clone containing the chromosomal DNA flanking the Tn917lac insertion localized the insertion to the extreme C-terminal end of the purA locus of S. aureus, which has been shown to reside in the SmaI-G fragment (40). These results position the ts mutation site near the purA locus of S. aureus. Three independently isolated overlapping clones were selected from a genomic library by complementation of the ts defect of the NT372 mutant. The shortest complementing clone, pMP373, contained an insert of 3,731 nucleotides; sequence analysis identified two complete ORFs, predicted to encode proteins of 233 and 608 amino acids. No ORFs were predicted within the first 650 bp of this clone, and two tRNA consensus motifs were identified in the genomic DNA proximal to the yycFG locus (Fig. (Fig.1).1 Searches against the GenBank database with the first putative ORF revealed a high degree of similarity to a number of RR genes. The highest degree of similarity observed was to yycF from the B. subtilis genomic sequence database (29); we found 89% amino acid similarity and 74% amino acid identity. Extensive similarity to PhoP (48) from B. subtilis was also noted, placing the product of this ORF in the OmpR-PhoB subfamily of RRs. Structural alignments with orthologues of YycF from other gram-positive organisms highlighted conserved features characteristic of RRs (Fig. (Fig.2).2
Searches with the second putative ORF revealed significant similarity to a number of HK genes. The highest degree of similarity observed was to an ORF designated yycG from B. subtilis (29); we found overall 69% similarity and 46% identity. Hydrophobicity analysis of the translated yycG ORF predicted two strongly hydrophobic stretches in the N-terminal third of the polypeptide, each consisting of a stretch of approximately 25 amino acids and bounding a hydrophilic sequence of 145 amino acids. In the absence of structural studies, these predictions suggested two membrane-spanning regions (TM1 and TM2) with an intervening cell surface loop that could define a sensory domain (6); the remaining hydrophilic C-terminal portion of the polypeptide, which contained sequence motifs characteristic of the kinase domains of HKs (39), could define a cytoplasmic signaling domain. Identification of the ts mutation in NT372. To determine the identity of yycF1, the genomic mutation causing the TS phenotype of NT372, genomic fragments containing yycFG were amplified by PCR from the chromosomal DNAs of wild-type strain SAM23 and ts mutant strain NT372. Sequence analysis of the PCR amplicons confirmed that a point mutation existed in the regulatory domain of the RR at nucleotide 187 (G187A), resulting in a predicted E63K variant polypeptide. The mutated residue (Lys) represents a nonconservative change from the acidic residues (Asp and Glu) usually occurring at this position (56). By comparison of the translated regulatory domain of yycF with the structurally characterized RR Spo0F from B. subtilis (14), the mutation is predicted to occur in the third α helix of the RR. This residue is a solvent-exposed side chain and may identify one point of interaction between this RR and its cognate HK. No other mutations in the NT372 genomic sequence were identified within the 3.7-kb region containing the yycFG locus. Phenotypic effects of the yycF1 mutation. Experiments designed to test the ability of NT372 cells to recover from a nonpermissive temperature incubation showed that the loss of YycF function had a bactericidal effect. Transient incubation of NT372 at a nonpermissive growth temperature (43°C, 2 h), followed by extended incubation at 30°C, resulted in less than 15% survival; longer incubation times at the higher temperature (43°C, 4 h) reduced the number of viable counts recovered at 30°C (<0.1% survival). Microscopic examination of the yycF1 mutants did not reveal gross changes in cell morphology or altered rates of autolysis when liquid cell cultures were shifted to the nonpermissive temperature. The yycF1 mutation caused novel nutritional requirements in chemically defined medium at permissive growth temperatures. An apparent Ilv− (isoleucine, leucine, and valine) auxotrophy was observed in both yycF1-containing strains (NT372 and SAM1010) but not in the corresponding wild-type strains (SAM23 and SAM1011). Single additions of isoleucine, leucine, or valine or of metabolic intermediates required for the biosynthesis of these amino acids (51) failed to correlate this apparent auxotrophy with a specific enzymatic defect. However, the combination of valine and pyruvate restored growth to the yycF1-containing strains, suggesting that the defect was related to branched-chain fatty acid biosynthesis, perhaps through improper regulation of 2-ketoisovalerate levels, rather than to an amino acid auxotrophy (15, 33). Additionally, this apparent auxotrophy could be corrected by supplementation with pantothenate, which is also required for branched-chain fatty acid biosynthesis as a precursor for coenzyme A (22). The possible connection between the apparent Ilv− phenotype of the yycF1 mutants and membrane integrity was investigated further. Certain long-chain cis unsaturated fatty acids (UFAs) are known to inhibit the growth of S. aureus (7), presumably by affecting the permeability of the membrane (17). A strain carrying the yycF1 mutation, SAM1010, was more susceptible to the bactericidal action of the long-chain cis UFAs linoleic acid and oleic acid than the isogenic wild-type strain, SAM1011 (Table 2). The in vitro interference of UFAs specifically in HK autophosphorylation has also been reported for KinA from B. subtilis (53); whether the observed hypersusceptibility was due to direct inhibition of YycG autophosphorylation or was an indication of altered membrane integrity is not currently known. Other phenotypic characteristics of S. aureus that might depend upon the integrity of the phospholipid bilayer, including the production of cell surface and secreted proteins (e.g., coagulase, lipase, and alpha-toxin), appeared to be unaffected in strains carrying the yycF1 mutation (data not shown).
The yycF1 mutation completely prevented growth in a variety of media at temperatures above 40°C; the rate of growth of the mutant was comparable to that of the wild type below 39°C. It was found that strain SAM1010 could grow under anoxic conditions in liquid media (Fig. (Fig.3)3
The yycF1 mutation affects resistance to MLSB antibiotics. The yycF1 mutation was also found to increase the susceptibility of S. aureus to macrolides and lincosamides, although not to other classes of antibiotics, including β-lactams, quinolones, aminoglycosides, and glycopeptides (Table 3). In addition, the Tn917lac insertions present in the isogenic strains SAM1010 and SAM1011, which bear the ermB resistance determinant (50), conferred different levels of Emr (Table 3). The NT372 mutant strain was fourfold more susceptible to erythromycin than was the unmutagenized parent, SAM23 (data not shown), suggesting that the difference might be indicative of a specific defect in the yycF1 strains. The mechanism of erm-encoded resistance to macrolide-lincosamide-streptogramin B (MLSB) antibiotics is well studied (58) and involves control by translational attenuation (2); accordingly, no difference in ermB mRNA levels was observed in samples from SAM1010 and SAM1011 (data not shown).
The differences in the susceptibilities of the SAM1010 mutant to the lincosamide antibiotics lincomycin hydrochloride, clindamycin hydrochloride, and clindamycin phosphate were large; the SAM1010 mutant was highly susceptible to lincomycin and clindamycin hydrochloride but not to clindamycin phosphate (Table 3). Since the YycF protein exhibits a high degree of similarity to other RRs of the PhoB subfamily, the effect of added Pi on the MICs of erythromycin and lincomycin was examined. A simple addition of Pi (100 μM) to the assay medium substantially increased the MIC of lincomycin from 0.25 μg/ml to >1,024 μg/ml for SAM1010; similar differences were noted for the two commercial preparations of clindamycin. No change in susceptibility to erythromycin was noted; since the lincosamides are more hydrophilic, factors governing susceptibility to the more hydrophobic erythromycin may be different (e.g., partitioning into the membrane [10]). Indeed, the addition of low levels of the UFA linoleic acid (2 ng/ml) to Mueller-Hinton medium significantly affected the MIC of erythromycin for SAM1010 (lowered it from 16 μg/ml to 0.25 μg/ml) but not for SAM1011 (>1,024 μg/ml under both conditions). These differences in macrolide and lincosamide susceptibility were influenced by the same conditions that influenced the growth of the yycF1 mutant SAM1010 at the semipermissive temperature; for example, the MIC of erythromycin for SAM1010 increased from 16 μg/ml to 256 μg/ml when the strain was grown under anoxic conditions at a neutral pH. It is interesting to note that this correction was only partial and that growth under anoxic conditions allowed the ts mutant to grow at 41°C but not at 43°C. Changes in the fatty acid compositions of membrane lipid pools have been observed to occur in S. aureus transitioning between aerobic growth and anaerobic growth (59); it is possible that an altered balance of fatty acids in this example led to the measured increase in resistance to erythromycin under anoxic growth conditions. Attempted insertional inactivation of yycFG. Two chromosomal integration constructs were created to achieve insertional disruption of either the RR (yycF) or the HK (yycG) ORF. By using the suicide plasmid pMP1008, the ermC gene was inserted either at the EcoRV site to disrupt the RR at amino acid 53, creating pMP626, or at the HpaI site to disrupt the HK at amino acid 344, creating pMP705 (Fig. (Fig.1).1 For comparison, the original suicide plasmid (pMP1008) was also integrated into the chromosome of SAM13 at the SmaI-G fragment, resulting in two complete copies of the yycFG locus with an intervening tetK marker. The resulting merodiploid strain, SAM1443, did not exhibit growth-related phenotypes distinct from those of the parental strain. In the absence of selection during overnight growth, resolution of the yycFG duplication was first identified by replica plating for the Tcs phenotype and then confirmed by genomic PCR and CHEF gel analysis. When this procedure was used, Tcs segregants arose from SAM1443 at 21 in 5,000 CFU. This result is in contrast to that for either of the tandem-duplication constructs. Attempts to resolve the tandem duplication and retain the chromosomal insertion in yycF or yycG were not successful in the absence of a wild-type copy of the gene; this finding held true for either disruption construct (SAM1156 and SAM1157). For both strains, resolution of the chromosomal tandem duplications was initially identified by the loss of the tetK marker and then scored for retention of the ermC insertion. In the absence of the rescue plasmid, Tcs segregants arose at 18 in 10,000 CFU; none of these resulting colonies (0 of 18) was Emr, indicating that the duplications had resolved without retaining the ermC insertion (Fig. (Fig.4).4
To demonstrate further the essential nature of the yycFG locus, attempts were made to transduce the chromosomal disruption of either ORF to a new set of strains either lacking or bearing a separate copy of the wild-type yycFG locus. To do this, a rescue plasmid (pMP782) constructed with the complementing clone from pMP373 (Fig. (Fig.1)1 DISCUSSION This work identifies a ts mutation in a two-component system from S. aureus that is essential for survival in vitro. An isogenic pair of strains, SAM1010 and SAM1011, was constructed from the original mutant (NT372) for further characterization by use of a closely linked Tn917lac chromosomal insertion. Strains carrying the yycF1 ts mutation exhibited attenuated virulence in two different in vivo models (4), implying that this system could be defined as essential for in vivo survival as well. Given the in vitro and in vivo effects of a ts mutation in the yycFG locus on the proliferation of S. aureus, this two-component system is an attractive target for antimicrobial compound screening. The yycF1 mutation causes hypersensitivity to macrolides. The yycF1 strain SAM1010 was affected in the phenotypic expression of MLSB resistance; this partial resistance could be influenced by the same environmental factors that influenced the TS phenotype. The observed differences in susceptibility to macrolides between SAM1010 and SAM1011 could be an indication either of increased permeability or of decreased efflux in the mutant (36). For example, macrolide susceptibility in S. aureus has been observed to increase markedly for strains bearing an insertional inactivation in either femAB (30) or lysC (3), both of which contribute to the structural integrity of the cell envelope. Conditional lethal alleles of genes involved in phospholipid biosynthesis in S. aureus, including pgsA (phosphatidylglycerol phosphate synthase; EC 2.7.8.5) and cdsA (phosphatidate cytidylyl transferase; EC 2.7.7.41), have also been found to confer hypersusceptibility to macrolides (32). Alternatively, disruption of the norA efflux pump in S. aureus results in hypersusceptibility to a number of antimicrobial compounds (21). Since the SAM1010 mutant is not broadly hypersusceptible to antibiotics, and those UFAs that are incorporated into membrane lipid pools at subinhibitory concentrations (16) also affect the erythromycin susceptibility of this mutant, it is proposed that the observed differences in susceptibility are due to a defect in the permeability barrier of the mutant. The yycFG locus encodes an essential HK-RR pair. Sequence analysis of the genomic DNA of the mutant confirmed that a point mutation existed in the genomic copy of the RR (encoded by yycF). The Glu-63 residue that occurs in the regulatory domain of the wild-type RR may contribute to the proper interaction with its cognate HK, whereas the Lys-63 variation in the mutant may destabilize the interaction of this HK-RR pair at a high temperature. Thus, a temperature shift to a nonpermissive temperature (43°C) may result in premature dissociation of the variant RR from the HK before an essential phosphotransfer event can occur. If the RR requires phosphorylation for activity (i.e., transcriptional activation), the conditional lethal phenotype would be recessive, as we have reported here, and thus suppressible in trans by a complete wild-type copy of the HK-RR pair. An attempt was made to disrupt the genomic copy of the yycFG locus to demonstrate its essential nature in vitro; toward this end, insertional inactivation constructs of either ORF were first established as tandem duplications in the chromosome. The inability to resolve the duplication while retaining the ermC insertion was used as an initial measure of the essential nature of this locus. Attempts to disrupt either the HK or the RR in the chromosome failed in the absence of a wild-type copy of the locus. In the presence of a plasmid-borne copy of the wild-type locus, it was possible to identify strains with a disrupted copy of either ORF in the chromosome. Once the resolution of the duplications was achieved, the inactivated loci could be transduced only to a recipient strain bearing a separate, functional copy of the locus. Importantly, environmental conditions that influenced the temperature sensitivity of mutant strains carrying yycF1, such as 0.5 M NaCl or exclusion of oxygen, did not allow the viability of strains with an insertional inactivation of yycF or yycG. Thus we believe that these conditions allow partial suppression of the effects of the variant YycF1 protein but do not bypass the essential function of the protein. The yycFG system regulates an essential process. Based upon unusually high peptide-level similarities (~89%), there are clear orthologues of this HK-RR pair in the genomes of other low-G+C-content gram-positive bacteria, including B. subtilis, Enterococcus faecalis, and Streptococcus pneumoniae. Similarly, these genomes also appear to contain distinct orthologues of genes encoding other members of the OmpR-PhoB subfamily of HK-RR pairs, including phoPR (48, 49) and resDE (55). Since phoPR and resDE have been demonstrated to interact in B. subtilis (54) and the modulation of at least one related environmental condition (i.e., anoxic growth conditions) significantly influences the growth of the ts mutant described here, it is possible that the yycFG system also plays a role in this regulatory network. The sensing of limiting phosphate levels by phoPR and how it might relate to the regulatory role of yycFG in S. aureus remain unclear; the response of S. aureus to phosphate limitation has only recently received extensive attention (57), and genetic studies characterizing the PHO regulon in this organism have not been reported. Studies characterizing the in vitro and in vivo pathway(s) regulated by yycFG and possible relationships to other members of the PHO regulon in S. aureus are currently under way. Several features of these genes make them uniquely suitable as targets for new antibiotic agents. A point mutation in the genomic copy of the RR confers a strongly bactericidal phenotype at a nonpermissive temperature, suggesting that inhibitors of this pathway would also have bactericidal effects. The mutant is also hypersusceptible to the bactericidal action of the UFAs linoleic acid and oleic acid, which are found at the sites of S. aureus infections (9, 61); it is possible that an inhibitor of this specific two-component system may render the bacteria more vulnerable to killing by the host. The essential nature of this system in the soil bacterium B. subtilis has been reported (13, 24); in addition to the findings reported here with S. aureus, this system may also play an essential role in other pathogens (e.g., E. faecalis) (Fig. (Fig.2),2 ACKNOWLEDGMENTS This work was supported in collaboration with the Robert Wood Johnson Pharmaceutical Research Institute. We acknowledge helpful discussions with Laura McDowell and Jerry Buysse and the technical assistance of Kelly Winterberg, Henry Fang, and Skip Bond. REFERENCES 1. Altschul S F, Gish W, Miller W, Myers E W, Lipman D J. Basic local alignment search tool. J Mol Biol. 1990;215:403–410. [PubMed] 2. Bechhofer D H, Zen K H. Mechanism of erythromycin-induced ermC mRNA stability in Bacillus subtilis. J Bacteriol. 1989;171:5803–5811. [PubMed] 3. Benton, B. Personal communication. 4. Bond, S. Personal communication. 5. Borodovsky M, Rudd K E, Koonin E V. Intrinsic and extrinsic approaches for detecting genes in a bacterial genome. Nucleic Acids Res. 1994;22:4756–4767. [PubMed] 6. Bourret R B, Borkovich K A, Simon M I. Signal transduction pathways involving protein phosphorylation in prokaryotes. Annu Rev Biochem. 1991;60:401–441. [PubMed] 7. Butcher G W, King G, Dyke K G. Sensitivity of Staphylococcus aureus to unsaturated fatty acids. J Gen Microbiol. 1976;94:290–296. [PubMed] 8. Camilli A, Portnoy A, Youngman P. Insertional mutagenesis of Listeria monocytogenes with a novel Tn917 derivative that allows direct cloning of DNA flanking transposon insertions. J Bacteriol. 1990;172:3738–3744. [PubMed] 9. Campbell I M, Crozier D N, Caton R B. Abnormal fatty acid composition and impaired oxygen supply in cystic fibrosis patients. Pediatrics. 1976;57:480–486. [PubMed] 10. Dette G A, Knothe H, Kaula S. Modifying effects of pH and temperature on (14C)erythromycin uptake into Staphylococcus aureus—relation to antimicrobial activity. Zentbl Bakteriol Mikrobiol Hyg A. 1987;265:393–403. 11. Devereux J, Haeberli P, Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 1984;12:387–395. [PubMed] 12. Dyer D W, Iandolo J J. Rapid isolation of DNA from Staphylococcus aureus. Appl Environ Microbiol. 1983;46:283–285. [PubMed] 13. Fabret C, Hoch J A. A two-component signal transduction system essential for growth of Bacillus subtilis: implications for anti-infective therapy. J Bacteriol. 1998;180:6375–6383. [PubMed] 14. Feher V A, Zapf J W, Hoch J A, Whiteley J M, McIntosh L P, Rance M, Skelton N J, Dahlquist F W, Cavanagh J. High-resolution NMR structure and backbone dynamics of the Bacillus subtilis response regulator, Spo0F: implications for phosphorylation and molecular recognition. Biochemistry. 1997;36:10015–10025. [PubMed] 15. Gollop N, Damri B, Chipman D M, Barak Z. Physiological implications of the substrate specificities of acetohydroxy acid synthases from varied organisms. J Bacteriol. 1990;172:3444–3449. [PubMed] 16. Greenway D L, Dyke K G. Isolation and properties of a linoleic acid-resistant mutant of Staphylococcus aureus. J Gen Microbiol. 1980;118:267–270. [PubMed] 17. Greenway D L, Dyke K G. Mechanism of the inhibitory action of linoleic acid on the growth of Staphylococcus aureus. J Gen Microbiol. 1979;115:233–245. [PubMed] 18. Hoch J A. Regulation of the phosphorelay and the initiation of sporulation in Bacillus subtilis. Annu Rev Microbiol. 1993;47:441–465. [PubMed] 19. Horinouchi S, Weisblum B. Nucleotide sequence and functional map of pC194, a plasmid that specifies inducible chloramphenicol resistance. J Bacteriol. 1982;150:815–825. [PubMed] 20. Hovde C J, Hackett S P, Bohach G A. Nucleotide sequence of the staphylococcal enterotoxin C3 gene: sequence comparison of all three type C staphylococcal enterotoxins. Mol Gen Genet. 1990;220:329–333. [PubMed] 21. Hsieh P C, Siegel S A, Rogers B, Davis D, Lewis K. Bacteria lacking a multidrug pump: a sensitive tool for drug discovery. Proc Natl Acad Sci USA. 1998;95:6602–6606. [PubMed] 22. Kaneda T. Iso- and anteiso-fatty acids in bacteria: biosynthesis, function, and taxonomic significance. Microbiol Rev. 1991;55:288–302. [PubMed] 23. Kanemasa Y, Yoshioka T, Hayashi H. Alteration of the phospholipid composition of Staphylococcus aureus cultured in medium containing NaCl. Biochim Biophys Acta. 1972;280:444–450. [PubMed] 24. Kasahara Y, Nakai S, Ogasawara N. Sequence analysis of the 36-kb region between gntZ and trnY genes of Bacillus subtilis genome. DNA Res. 1997;4:155–159. [PubMed] 25. Kennelly P J, Potts M. Fancy meeting you here! a fresh look at “prokaryotic” protein phosphorylation. J Bacteriol. 1996;178:4759–4764. [PubMed] 25a. Ketchum, K. A. 5 August 1998. Sequences. [Online.] http://www.tigr.org/. [5 May 1999, last date accessed.]. 26. Kleckner N, Roth J, Botstein D. Genetic engineering in vivo using translocatable drug-resistance elements. New methods in bacterial genetics. J Mol Biol. 1977;116:125–159. [PubMed] 27. Kohno T, Schmid M, Roth J R. Effect of electrolytes on growth of mutant bacteria. Basic Life Sci. 1979;14:53–57. [PubMed] 28. Kreiswirth B N, Lofdahl S, Betley M J, O’Reilly M, Schlievert P M, Bergdoll M S, Novick R P. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature. 1983;305:709–712. [PubMed] 29. Kunst F, Ogasawara N, Moszer I, Albertini A M, Alloni G, Azevedo V, Bertero M G, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell S C, Bron S, Brouillet S, Bruschi C V, Caldwell B, Capuano V, Carter N M, Choi S K, Codani J J, Connerton I F, Danchin A, et al. The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997;390:249–256. [PubMed] 30. Ling B, Berger-Bachi B. Increased overall antibiotic susceptibility in Staphylococcus aureus femAB null mutants. Antimicrob Agents Chemother. 1998;42:936–938. [PubMed] 31. Manson M D, Armitage J P, Hoch J A, Macnab R M. Bacterial locomotion and signal transduction. J Bacteriol. 1998;180:1009–1022. [PubMed] 32. Martin, P. K. Unpublished data. 33. Massey L K, Sokatch J R, Conrad R S. Branched-chain amino acid catabolism in bacteria. Bacteriol Rev. 1976;40:42–54. [PubMed] 34. Miller J F, Mekalanos J J, Falkow S. Coordinate regulation and sensory transduction in the control of bacterial virulence. Science. 1989;243:916–922. [PubMed] 35. Mojumdar M, Khan S A. Characterization of the tetracycline resistance gene of plasmid pT181 of Staphylococcus aureus. J Bacteriol. 1988;170:5522–5528. [PubMed] 36. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science. 1994;264:382–388. [PubMed] 37. Novick R. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology. 1967;33:155–166. [PubMed] 38. Parkinson J S. Signal transduction schemes of bacteria. Cell. 1993;73:857–871. [PubMed] 39. Parkinson J S, Kofoid E C. Communication modules in bacterial signaling proteins. Annu Rev Genet. 1992;26:71–112. [PubMed] 40. Pattee P A, Lee H C, Bannantine J P. Genetic and physical mapping of the chromosome of Staphylococcus aureus. In: Novick R P, editor. Molecular biology of the staphylococci. New York, N.Y: VCH; 1990. pp. 41–58. 41. Pattee P A, Neveln D S. Transformation analysis of three linkage groups in Staphylococcus aureus. J Bacteriol. 1975;124:201–211. [PubMed] 42. Perkins J B, Youngman P J. Construction and properties of Tn917-lac, a transposon derivative that mediates transcriptional gene fusions in Bacillus subtilis. Proc Natl Acad Sci USA. 1986;83:140–144. [PubMed] 43. Quon K C, Marczynski G T, Shapiro L. Cell cycle control by an essential bacterial two-component signal transduction protein. Cell. 1996;84:83–93. [PubMed] 44. Quon K C, Yang B, Domain I J, Shapiro L, Marczynski G T. Negative control of bacterial DNA replication by a cell cycle regulatory protein that binds at the chromosome origin. Proc Natl Acad Sci USA. 1998;95:120–125. [PubMed] 44a. Roe, B. A. 5 August 1998. Sequences. [Online.] http://www.genome.ou.edu/. [5 May 1999, last date accessed.]. 45. Sambrook J, Fritsch E F, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory Press; 1989. 46. Sanderson K E, Roth J R. Linkage map of Salmonella typhimurium, edition VII. Microbiol Rev. 1988;52:485–532. [PubMed] 47. Schroeder C J, Pattee P A. Transduction analysis of transposon Tn551 insertions in the trp-thy region of the Staphylococcus aureus chromosome. J Bacteriol. 1984;157:533–537. [PubMed] 48. Seki T, Yoshikawa H, Takahashi H, Saito H. Cloning and nucleotide sequence of phoP, the regulatory gene for alkaline phosphatase and phosphodiesterase in Bacillus subtilis. J Bacteriol. 1987;169:2913–2916. [PubMed] 49. Seki T, Yoshikawa H, Takahashi H, Saito H. Nucleotide sequence of the Bacillus subtilis phoR gene. J Bacteriol. 1988;170:5935–5938. [PubMed] 50. Shaw J H, Clewell D B. Complete nucleotide sequence of macrolide-lincosamide-streptogramin B resistance transposon Tn917 in Streptococcus faecalis. J Bacteriol. 1985;164:782–796. [PubMed] 51. Smith C D, Pattee P A. Biochemical and genetic analysis of isoleucine and valine biosynthesis in Staphylococcus aureus. J Bacteriol. 1967;93:1832–1838. [PubMed] 52. Stock J B, Ninfa A J, Stock A M. Protein phosphorylation and regulation of adaptive responses in bacteria. Microbiol Rev. 1989;53:450–490. [PubMed] 53. Strauch M A, de Mendoza D, Hoch J A. cis-Unsaturated fatty acids specifically inhibit a signal-transducing protein kinase required for initiation of sporulation in Bacillus subtilis. Mol Microbiol. 1992;6:2909–2917. [PubMed] 54. Sun G, Birkey S M, Hulett F M. Three two-component signal-transduction systems interact for Pho regulation in Bacillus subtilis. Mol Microbiol. 1996;19:941–948. [PubMed] 55. Sun G, Sharkova E, Chesnut R, Birkey S, Duggan M F, Sorokin A, Pujic P, Ehrlich S D, Hulett F M. Regulators of aerobic and anaerobic respiration in Bacillus subtilis. J Bacteriol. 1996;178:1374–1385. [PubMed] 56. Volz K. Structural conservation in the CheY superfamily. Biochemistry. 1993;32:11741–11753. [PubMed] 57. Watson S P, Clements M O, Foster S J. Characterization of the starvation-survival response of Staphylococcus aureus. J Bacteriol. 1998;180:1750–1758. [PubMed] 58. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother. 1995;39:577–585. [PubMed] 59. White D C, Frerman F E. Fatty acid composition of the complex lipids of Staphylococcus aureus during the formation of the membrane-bound electron transport system. J Bacteriol. 1968;95:2198–2209. [PubMed] 60. Wu J, Ohta N, Newton A. An essential, multicomponent signal transduction pathway required for cell cycle regulation in Caulobacter. Proc Natl Acad Sci USA. 1998;95:1443–1448. [PubMed] 61. Xiong Z, Ge S, Chamberlain N R, Kapral F A. Growth cycle-induced changes in sensitivity of Staphylococcus aureus to bactericidal lipids from abscesses. J Med Microbiol. 1993;39:58–63. [PubMed] 62. Youngman P, Perkins J B, Losick R. A novel method for the rapid cloning in Escherichia coli of Bacillus subtilis chromosomal DNA adjacent to Tn917 insertions. Mol Gen Genet. 1984;195:424–433. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Annu Rev Biochem. 1991; 60():401-41.
[Annu Rev Biochem. 1991]Cell. 1993 Jun 4; 73(5):857-71.
[Cell. 1993]Microbiol Rev. 1989 Dec; 53(4):450-90.
[Microbiol Rev. 1989]Annu Rev Microbiol. 1993; 47():441-65.
[Annu Rev Microbiol. 1993]Science. 1989 Feb 17; 243(4893):916-22.
[Science. 1989]Proc Natl Acad Sci U S A. 1998 Feb 17; 95(4):1443-8.
[Proc Natl Acad Sci U S A. 1998]Proc Natl Acad Sci U S A. 1998 Jan 6; 95(1):120-5.
[Proc Natl Acad Sci U S A. 1998]Cell. 1996 Jan 12; 84(1):83-93.
[Cell. 1996]J Bacteriol. 1996 Mar; 178(5):1374-85.
[J Bacteriol. 1996]J Bacteriol. 1998 Dec; 180(23):6375-83.
[J Bacteriol. 1998]J Bacteriol. 1975 Oct; 124(1):201-11.
[J Bacteriol. 1975]J Bacteriol. 1984 Feb; 157(2):533-7.
[J Bacteriol. 1984]Appl Environ Microbiol. 1983 Jul; 46(1):283-5.
[Appl Environ Microbiol. 1983]Nucleic Acids Res. 1984 Jan 11; 12(1 Pt 1):387-95.
[Nucleic Acids Res. 1984]Nucleic Acids Res. 1994 Nov 11; 22(22):4756-67.
[Nucleic Acids Res. 1994]J Mol Biol. 1990 Oct 5; 215(3):403-10.
[J Mol Biol. 1990]Proc Natl Acad Sci U S A. 1986 Jan; 83(1):140-4.
[Proc Natl Acad Sci U S A. 1986]J Mol Biol. 1977 Oct 15; 116(1):125-59.
[J Mol Biol. 1977]Microbiol Rev. 1988 Dec; 52(4):485-532.
[Microbiol Rev. 1988]Mol Gen Genet. 1984; 195(3):424-33.
[Mol Gen Genet. 1984]Nature. 1997 Nov 20; 390(6657):249-56.
[Nature. 1997]J Bacteriol. 1987 Jul; 169(7):2913-6.
[J Bacteriol. 1987]Nature. 1997 Nov 20; 390(6657):249-56.
[Nature. 1997]Annu Rev Biochem. 1991; 60():401-41.
[Annu Rev Biochem. 1991]Annu Rev Genet. 1992; 26():71-112.
[Annu Rev Genet. 1992]Biochemistry. 1993 Nov 9; 32(44):11741-53.
[Biochemistry. 1993]Biochemistry. 1997 Aug 19; 36(33):10015-25.
[Biochemistry. 1997]J Bacteriol. 1967 Jun; 93(6):1832-8.
[J Bacteriol. 1967]J Bacteriol. 1990 Jun; 172(6):3444-9.
[J Bacteriol. 1990]Bacteriol Rev. 1976 Mar; 40(1):42-54.
[Bacteriol Rev. 1976]Microbiol Rev. 1991 Jun; 55(2):288-302.
[Microbiol Rev. 1991]J Gen Microbiol. 1976 Jun; 94(2):290-6.
[J Gen Microbiol. 1976]J Gen Microbiol. 1979 Nov; 115(1):233-45.
[J Gen Microbiol. 1979]Mol Microbiol. 1992 Oct; 6(20):2909-17.
[Mol Microbiol. 1992]Basic Life Sci. 1979; 14():53-7.
[Basic Life Sci. 1979]Biochim Biophys Acta. 1972 Nov 30; 280(3):444-50.
[Biochim Biophys Acta. 1972]J Bacteriol. 1985 Nov; 164(2):782-96.
[J Bacteriol. 1985]Antimicrob Agents Chemother. 1995 Mar; 39(3):577-85.
[Antimicrob Agents Chemother. 1995]J Bacteriol. 1989 Nov; 171(11):5803-11.
[J Bacteriol. 1989]J Bacteriol. 1968 Jun; 95(6):2198-209.
[J Bacteriol. 1968]Science. 1994 Apr 15; 264(5157):382-8.
[Science. 1994]Antimicrob Agents Chemother. 1998 Apr; 42(4):936-8.
[Antimicrob Agents Chemother. 1998]Proc Natl Acad Sci U S A. 1998 Jun 9; 95(12):6602-6.
[Proc Natl Acad Sci U S A. 1998]J Gen Microbiol. 1980 May; 118(1):267-70.
[J Gen Microbiol. 1980]J Bacteriol. 1987 Jul; 169(7):2913-6.
[J Bacteriol. 1987]J Bacteriol. 1988 Dec; 170(12):5935-8.
[J Bacteriol. 1988]J Bacteriol. 1996 Mar; 178(5):1374-85.
[J Bacteriol. 1996]Mol Microbiol. 1996 Mar; 19(5):941-8.
[Mol Microbiol. 1996]J Bacteriol. 1998 Apr; 180(7):1750-8.
[J Bacteriol. 1998]Pediatrics. 1976 Apr; 57(4):480-6.
[Pediatrics. 1976]J Med Microbiol. 1993 Jul; 39(1):58-63.
[J Med Microbiol. 1993]J Bacteriol. 1998 Dec; 180(23):6375-83.
[J Bacteriol. 1998]DNA Res. 1997 Apr 28; 4(2):155-9.
[DNA Res. 1997]Biochemistry. 1993 Nov 9; 32(44):11741-53.
[Biochemistry. 1993]